Elixinol Wellness (ASX:EXL) Forward PE Ratio: 0.00 (As of Jul. 08, 2026)


What is Elixinol Wellness Forward PE Ratio?

Elixinol Wellness ASX:EXL Forward PE Ratio is 0.00 as of Jul. 08, 2026. The stock has 7 warning signs investors should review. Among 408 Drug Manufacturers companies, Elixinol Wellness ranks worse than 245097.79% on this metric.

Elixinol Wellness's Forward PE Ratio for today is 0.00.

Elixinol Wellness's PE Ratio without NRI for today is 0.00.

Elixinol Wellness's PE Ratio (TTM) for today is 0.00.

Elixinol Wellness  (ASX:EXL) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

Elixinol Wellness Forward PE Ratio Related Terms

Elixinol Wellness Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for Elixinol Wellness's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elixinol Wellness Forward PE Ratio Chart

Elixinol Wellness Annual Data
Trend
Forward PE Ratio

Elixinol Wellness Semi-Annual Data
2019-06
Forward PE Ratio 256.41

ASX:EXL vs ZTS, UTHR, VTRS: Forward PE Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Elixinol Wellness's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elixinol Wellness Forward PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixinol Wellness's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Elixinol Wellness's Forward PE Ratio falls into.


Elixinol Wellness Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 0.00 mean?
Elixinol Wellness (ASX:EXL) has a Forward PE Ratio of 0.00 as of Jul. 08, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Elixinol Wellness and its competitors. According to the industry distribution chart, Elixinol Wellness ranks #999999 out of 408 companies in the Drug Manufacturers industry.
Is Elixinol Wellness' Forward PE Ratio too high?
Elixinol Wellness' current Forward PE Ratio is 0.00. Based on the distribution chart, Elixinol Wellness ranks #999999 out of 408 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Elixinol Wellness' Forward PE Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Elixinol Wellness ranks #999999 out of 408 companies for Forward PE Ratio. This places Elixinol Wellness in the lower half of its industry. The industry median Forward PE Ratio is 17.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Drug Manufacturers company?
The median Forward PE Ratio among Drug Manufacturers companies is 17.36, based on 408 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Elixinol Wellness and its competitors. For the Drug Manufacturers industry, the median Forward PE Ratio is 17.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elixinol Wellness's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elixinol Wellness stock overvalued right now?
Based on GuruFocus' analysis, Elixinol Wellness (ASX:EXL) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.01 — trading 70% below its estimated fair value. The current Forward PE Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Elixinol Wellness (ASX:EXL), the current Forward PE Ratio is 0.00 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Elixinol Wellness Business Description

Other Exchanges ELLXF:USAE8M:Germany
Address 51 - 53 Riversdale Road, Newtown, VIC, AUS, 3220
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries. It derives maximum revenue from Australia.